ISPO

Risk Assessment II

A meta-analysis of painting exposure and cancer death

R Chen MD, A Seaton MD

Infrared pathology: a new diagnostic and prognostic indicator

HH Mantsch PhD, C Schultz PhD, K-Z Liu MD, PH Watson PhD, JB Johnston MD, M Jackson PhD

Protein kinase CK2 as a prognostic marker and antisense target in head and neck cancer

RA Faust MD PhD, G Gapany MD, L Bubash MD, AT Davis BS, G Adams MD, K Ahmed PhD

Proliferation rates and DNA-index in aneuploid neuroblastoma

LM Ball MB BS, K Laybolt RT, C Riddell PhD, L Resch MD, R Frazer MD, JR Wright Jr MD PhD, D van Velzen MD PhD

Ploidy-related, clonal DNA concentration discontinuity in the assessment of prognosis in mixed neuroblastoma

LM Ball MB BS, K Laybolt RT, C Lannon BSc, D van Velzen MD PhD

Modified elisa for simple quantitation of TRK in neuroblastomas

H Iwata MD PhD, T Muto MD PhD, Y Ishiguro MD PhD, M Hamaguchi MD PhD

Oral pre-malignant lesions: risk assessment by fluorescence in situ-hybridization (fish)

C Lenz, A Pfuhl, R Erber, H Weidauer, FX Bosch

Transsternal cervicomediastinal microdissection in medullary thyroid carcinoma - is a tumor-related approach justified?

O Gimm MD, H Dralle MD

Lea.135: a novel favorable prognostic biomarker for patients with primary breast cancer

SA Imam PhD, B Chaiwun MD, ME Dunn BS, SG Groshen PhD, AM Neville MD PhD, H Torloni MD, RJ Cote MD, CR Taylor MD PhD

Application of multiprocess dynamic linear time series model

P Winkel, M Brandt-Lassen, U Leth-Dahl, S Lundbye-Christensen, G Soletormos

Prognostic evaluation of locally advanced gastric cancer patients with preoperative downstaging chemotherapy

H Nakano MD, K Namatame MD, M Yamaguchi MD, T Midorikawa MD, Y Yoshizawa MD, K Kumada MD

High proliferation rates in wilms limited to aneuploid lesions

K Laybolt, LM Ball MB BS, R Frazer MD, L Resch MD, JR Wright Jr MD PhD, C Lannon BSc, D van Velzen MD PhD

Prognostic value of agnors in renal cell carcinoma: results of a prospective study

A Pich MD, E Margaria MD, L Chiusa MD, A Formiconi MD, A Stramignoni MD

Prognostic significance of flow cytometric deoxyribonucleic acid ploidy for patients with superficial bladder cancer: a long-term followup study

M Tachibana MD, A Miyakawa MD, S Saito MD, K Nakamura MD, S Baba MD, M Nural MD